The Head of the Crypto Task Force weighs in on memecoins, investor protections, and how the SEC plans to safeguard crypto ...
2d
GlobalData on MSNMural Oncology’s Phase III ovarian cancer trial failure knocks stock by 57%Mural Oncology’s Phase III trial of nemvaleukin alfa alongside Keytruda saw just a 0.3 month gain in overall survival over ...
Nearly a year has passed since the stock market regulator consented to the issuance of a Tk660 crore zero-coupon bond and Tk350 crore preference shares, but both capital-raising efforts for short-term ...
The artificial intelligence spending frenzy has catapulted Nvidia's share price and turned Nvidia into a household name akin ...
Lithium Royalty Corp's IPO struggles amid falling lithium prices. Learn about their high-risk strategy, financial challenges, ...
Concerns about an imminent US recession are casting a shadow over Wall Street, driving the Nasdaq 100 (NDX), S&P 500 (SPX), ...
Humacyte's stock struggles despite FDA approval for Symvess, with financial concerns and slow adoption impacting future ...
The downgrade of CBG’s senior unsecured rating to Baa1 reflects the downgrade of CBL’s BCA to baa1, and moderate loss severity for this instrument under Moody’s Advanced Loss Given Failure analysis.
For years, Pakistanis have locked their money into ‘safe’ but unproductive assets, avoiding risk like it’s a contagious ...
ORLANDO, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management ("Abacus” or the "Company”) (NASDAQ: ABL), a ...
2d
Stocktwits on MSNCorMedix Stock Loses Almost A Third Of Its Market Cap After Downbeat H1 Revenue Outlook – But Retail Shrugs It OffCorMedix (CRMD), on Tuesday, lost nearly a third of its market capitalization after the company’s first-half 2025 outlook ...
(Reuters) - Britain’s Heathrow Airport said on Friday it will be closed until midnight after experiencing a significant power ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results